The Late Stage Chronic Kidney Disease Drugs market size is expected to reach $13.59 billion in 2030 at a CAGR of 11.7%, driven by CKD prevalence.
Read MoreThe Lactose Intolerance Treatment market size is expected to reach $49.13 billion in 2030 at a CAGR of 7.4%, driven by rising global population.
Read MoreThe Lactation Support Supplements market size is expected to reach $1.34 billion in 2030 at a CAGR of 7.0%, driven by working mothers growth.
Read MoreThe Lab Automation in Drug Discovery market size is expected to reach $8.72 billion in 2030 at a CAGR of 5.2%, driven by precision medicine demand.
Read MoreThe Lactation Support Supplements market size is expected to reach $1.34 billion in 2030 at a CAGR of 7.0%, driven by working mothers growth.
Read MoreThe Lab Automation in Drug Discovery market size is expected to reach $8.72 billion in 2030 at a CAGR of 5.2%, driven by precision medicine demand.
Read MoreThe G-CSF (Granulocyte Colony Stimulating Factors) market size is expected to reach $12.21 billion in 2030 at a CAGR of 5.3%, driven by rising cancer prevalence.
Read MoreThe Gastroparesis Drugs market size is expected to reach $7.37 billion in 2030 at a CAGR of 5.2%, driven by rising diabetes prevalence.
Read MoreThe Gastrointestinal Therapeutics market size is expected to reach $55.21 billion in 2030 at a CAGR of 5.4%, driven by rising inflammatory bowel diseases.
Read MoreThe Gastrointestinal Over-The-Counter (OTC) Drugs market size is expected to reach $73.3 billion in 2030 at a CAGR of 8.1%, driven by rising digestive disorders.
Read More